
Nancy J. Leith
Examiner (ID: 11817)
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1805, 1815, 1636, 1811, 1941 |
| Total Applications | 1439 |
| Issued Applications | 991 |
| Pending Applications | 201 |
| Abandoned Applications | 279 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20350075
[patent_doc_number] => 20250346927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-11-13
[patent_title] => METHODS AND COMPOSITIONS FOR MODULATING A GENOME
[patent_app_type] => utility
[patent_app_number] => 19/272775
[patent_app_country] => US
[patent_app_date] => 2025-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 162556
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19272775
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/272775 | METHODS AND COMPOSITIONS FOR MODULATING A GENOME | Jul 16, 2025 | Pending |
Array
(
[id] => 20288621
[patent_doc_number] => 20250313864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-09
[patent_title] => TYPE V CAS PROTEINS AND APPLICATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 19/232045
[patent_app_country] => US
[patent_app_date] => 2025-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61726
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19232045
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/232045 | Type V Cas proteins and applications thereof | Jun 8, 2025 | Issued |
Array
(
[id] => 20165320
[patent_doc_number] => 20250257366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-14
[patent_title] => DNA ORIGAMI ENCODING FOR GENE EXPRESSION AND CONTRANSFECTION
[patent_app_type] => utility
[patent_app_number] => 19/193742
[patent_app_country] => US
[patent_app_date] => 2025-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12339
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19193742
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/193742 | DNA ORIGAMI ENCODING FOR GENE EXPRESSION AND CONTRANSFECTION | Apr 28, 2025 | Pending |
Array
(
[id] => 20165320
[patent_doc_number] => 20250257366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-14
[patent_title] => DNA ORIGAMI ENCODING FOR GENE EXPRESSION AND CONTRANSFECTION
[patent_app_type] => utility
[patent_app_number] => 19/193742
[patent_app_country] => US
[patent_app_date] => 2025-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12339
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19193742
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/193742 | DNA ORIGAMI ENCODING FOR GENE EXPRESSION AND CONTRANSFECTION | Apr 28, 2025 | Pending |
Array
(
[id] => 20288620
[patent_doc_number] => 20250313863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-09
[patent_title] => ENGINEERED CIRCULARIZED pegRNAs AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 19/174171
[patent_app_country] => US
[patent_app_date] => 2025-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79433
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19174171
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/174171 | ENGINEERED CIRCULARIZED pegRNAs AND USES THEREOF | Apr 8, 2025 | Pending |
Array
(
[id] => 20279733
[patent_doc_number] => 20250304975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-02
[patent_title] => APTAMER AND RIBOZYME EQUILIBRIUM SHIFTING (ARES) RNA CIRCUITS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 19/092639
[patent_app_country] => US
[patent_app_date] => 2025-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41566
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19092639
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/092639 | APTAMER AND RIBOZYME EQUILIBRIUM SHIFTING (ARES) RNA CIRCUITS AND USES THEREOF | Mar 26, 2025 | Pending |
Array
(
[id] => 20249161
[patent_doc_number] => 20250298030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-25
[patent_title] => Compositions and Methods for NK-92 Cells Expressing Native CD16
[patent_app_type] => utility
[patent_app_number] => 19/085903
[patent_app_country] => US
[patent_app_date] => 2025-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2643
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19085903
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/085903 | Compositions and Methods for NK-92 Cells Expressing Native CD16 | Mar 19, 2025 | Pending |
Array
(
[id] => 20100511
[patent_doc_number] => 20250230447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-17
[patent_title] => EXPRESSION SYSTEM FOR PRODUCT MANUFACTURING
[patent_app_type] => utility
[patent_app_number] => 19/066066
[patent_app_country] => US
[patent_app_date] => 2025-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15932
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19066066
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/066066 | Expression system for product manufacturing | Feb 26, 2025 | Issued |
Array
(
[id] => 20050265
[patent_doc_number] => 20250188487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-12
[patent_title] => NON-IMMUNOGENIC CIRCULAR, NON-VIRAL DNA VECTORS
[patent_app_type] => utility
[patent_app_number] => 19/064383
[patent_app_country] => US
[patent_app_date] => 2025-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27747
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19064383
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/064383 | Non-immunogenic circular, non-viral DNA vectors | Feb 25, 2025 | Issued |
Array
(
[id] => 20025295
[patent_doc_number] => 20250163517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-22
[patent_title] => METHODS FOR SEQUENCING SAMPLES
[patent_app_type] => utility
[patent_app_number] => 19/028916
[patent_app_country] => US
[patent_app_date] => 2025-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17371
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19028916
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/028916 | Methods for sequencing samples | Jan 16, 2025 | Issued |
Array
(
[id] => 20193793
[patent_doc_number] => 20250270503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-28
[patent_title] => Product, system and method of cell cultivation
[patent_app_type] => utility
[patent_app_number] => 19/028930
[patent_app_country] => US
[patent_app_date] => 2025-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 125081
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19028930
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/028930 | Product, system and method of cell cultivation | Jan 16, 2025 | Pending |
Array
(
[id] => 20025295
[patent_doc_number] => 20250163517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-22
[patent_title] => METHODS FOR SEQUENCING SAMPLES
[patent_app_type] => utility
[patent_app_number] => 19/028916
[patent_app_country] => US
[patent_app_date] => 2025-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17371
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19028916
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/028916 | Methods for sequencing samples | Jan 16, 2025 | Issued |
Array
(
[id] => 20023269
[patent_doc_number] => 20250161491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-22
[patent_title] => SUPPLEMENTATION OF LIVER ENZYME EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 18/959371
[patent_app_country] => US
[patent_app_date] => 2024-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50542
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18959371
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/959371 | SUPPLEMENTATION OF LIVER ENZYME EXPRESSION | Nov 24, 2024 | Pending |
Array
(
[id] => 19862674
[patent_doc_number] => 20250101460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-27
[patent_title] => Controllable Transcription
[patent_app_type] => utility
[patent_app_number] => 18/941863
[patent_app_country] => US
[patent_app_date] => 2024-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24020
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18941863
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/941863 | Controllable transcription | Nov 7, 2024 | Issued |
Array
(
[id] => 19862630
[patent_doc_number] => 20250101416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-27
[patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF TRANSTHYRETIN AMYLOIDOSIS
[patent_app_type] => utility
[patent_app_number] => 18/900481
[patent_app_country] => US
[patent_app_date] => 2024-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30140
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18900481
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/900481 | COMPOSITIONS AND METHODS FOR TREATMENT OF TRANSTHYRETIN AMYLOIDOSIS | Sep 26, 2024 | Pending |
Array
(
[id] => 19862630
[patent_doc_number] => 20250101416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-27
[patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF TRANSTHYRETIN AMYLOIDOSIS
[patent_app_type] => utility
[patent_app_number] => 18/900481
[patent_app_country] => US
[patent_app_date] => 2024-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30140
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18900481
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/900481 | COMPOSITIONS AND METHODS FOR TREATMENT OF TRANSTHYRETIN AMYLOIDOSIS | Sep 26, 2024 | Pending |
Array
(
[id] => 19615371
[patent_doc_number] => 20240401051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => TUNING CASCADE ASSAY KINETICS VIA MOLECULAR DESIGN
[patent_app_type] => utility
[patent_app_number] => 18/805534
[patent_app_country] => US
[patent_app_date] => 2024-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30782
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 480
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18805534
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/805534 | Tuning cascade assay kinetics via molecular design | Aug 14, 2024 | Issued |
Array
(
[id] => 19643237
[patent_doc_number] => 20240417757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-19
[patent_title] => METHODS AND COMPOSITIONS FOR MODULATING A GENOME
[patent_app_type] => utility
[patent_app_number] => 18/805023
[patent_app_country] => US
[patent_app_date] => 2024-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 147878
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18805023
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/805023 | Methods and compositions for modulating a genome | Aug 13, 2024 | Issued |
Array
(
[id] => 19572170
[patent_doc_number] => 20240376462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => ENGINEERED CLASS 2 TYPE V CRISPR SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 18/789158
[patent_app_country] => US
[patent_app_date] => 2024-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 120411
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18789158
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/789158 | ENGINEERED CLASS 2 TYPE V CRISPR SYSTEMS | Jul 29, 2024 | Pending |
Array
(
[id] => 19234042
[patent_doc_number] => 20240191234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => TUNING CASCADE ASSAY KINETICS VIA MOLECULAR DESIGN
[patent_app_type] => utility
[patent_app_number] => 18/586417
[patent_app_country] => US
[patent_app_date] => 2024-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30438
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 365
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18586417
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/586417 | Tuning cascade assay kinetics via molecular design | Feb 22, 2024 | Issued |